This document is an excerpt from the EUR-Lex website
Document 22026D0033
Decision of the EEA Joint Committee No 187/2025 of 19 September 2025 amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/33]
Decision of the EEA Joint Committee No 187/2025 of 19 September 2025 amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/33]
Decision of the EEA Joint Committee No 187/2025 of 19 September 2025 amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/33]
OJ L, 2026/33, 15.1.2026, ELI: http://data.europa.eu/eli/dec/2026/33/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
Official Journal |
EN L series |
|
2026/33 |
15.1.2026 |
DECISION OF THE EEA JOINT COMMITTEE No 187/2025
of 19 September 2025
amending Annex I (Veterinary and phytosanitary matters) and Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2026/33]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2024/2598 of 4 October 2024 laying down the list of third countries or regions thereof authorised for the entry into the Union of certain animals and products of animal origin intended for human consumption in accordance with Regulation (EU) 2017/625 of the European Parliament and of the Council as regards the application of the prohibition on the use of certain antimicrobial medicinal products (1) is to be incorporated into the EEA Agreement. |
|
(2) |
This Decision concerns, inter alia, legislation regarding live animals other than fish and aquaculture animals and animal products such as ova, embryo and semen. Legislation concerning these matters shall not apply to Iceland, as specified in paragraph 2 of the Introductory Part of Chapter I of Annex I to the EEA Agreement. |
|
(3) |
This Decision concerns legislation regarding veterinary matters and foodstuffs. Legislation regarding veterinary matters and foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the sectoral adaptations to Annex I and the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein. |
|
(4) |
Annexes I and II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following is inserted after point 11bzg (Commission Delegated Regulation (EU) 2024/2104) in Part 1.1 of Chapter I of Annex I to the EEA Agreement:
|
‘11bzh. |
32024 R 2598: Commission Implementing Regulation (EU) 2024/2598 of 4 October 2024 laying down the list of third countries or regions thereof authorised for the entry into the Union of certain animals and products of animal origin intended for human consumption in accordance with Regulation (EU) 2017/625 of the European Parliament and of the Council as regards the application of the prohibition on the use of certain antimicrobial medicinal products (OJ L, 2024/2598, 7.10.2024). This act shall apply to Iceland for the areas referred to in paragraph 2 of the Introductory Part.’ |
Article 2
The following point is inserted after point 164zh (Commission Delegated Regulation (EU) 2024/2104) of Chapter XII of Annex II to the EEA Agreement:
|
‘164zi. |
32024 R 2598: Commission Implementing Regulation (EU) 2024/2598 of 4 October 2024 laying down the list of third countries or regions thereof authorised for the entry into the Union of certain animals and products of animal origin intended for human consumption in accordance with Regulation (EU) 2017/625 of the European Parliament and of the Council as regards the application of the prohibition on the use of certain antimicrobial medicinal products (OJ L, 2024/2598, 7.10.2024).’ |
Article 3
The text of Implementing Regulation (EU) 2024/2598 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 4
This Decision shall enter into force on 20 September 2025, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 5
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 19 September 2025.
For the EEA Joint Committee
The President
Stefán Haukur JÓHANNESSON
(1) OJ L, 2024/2598, 7.10.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2598/oj.
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2026/33/oj
ISSN 1977-0677 (electronic edition)